About Us

Direct Biologics is a market leading innovator and science-based cGMP manufacturer of regenerative biologic products. The Company is committed to providing the latest clinical and scientific information through rigorous and thorough research.

With deep knowledge and industry expertise in cellular and regenerative therapies, the company has brought to market a significant development in therapeutic biologics with the introduction of the highest quality production of extracellular vesicles.

Innovation

Direct Biologics was created to expand the science of cutting-edge human cell and tissue technologies through research and has built extensive intellectual property surrounding stem cells and their utility.


Safety

Direct Biologics is committed to patient safety. All regulated processes are compliant with cGxP to ensure the highest safety and quality throughout every stage of our product.


Quality

Direct Biologics provides quality products for healthcare providers and patients. Exceptional quality standards are maintained by continuous improvement of the quality system to provide safe and consistent products.

Our Team

Direct Biologics’ management team holds extensive collective experience in biologics research, development, and commercialization, making the Company a leader in the evolving, next generation segment of the biotherapeutics industry.

Mark Adams

Co-Founder & Chief Executive Officer

JV

John Vacalis

President and Chief Legal Officer

Paul BW v3

Paul Tebbey

Chief Operating Officer

Jeff Mims

Chief Financial Officer

BM

Bruce Middleton

Senior Vice President, Operations

Travis New

Travis Frick

Vice President, Manufacturing

John Constantine

Director, Investor Relations

Cinta

Cinta Burgos

Vice Pres. Quality & Regulatory Affairs

0115Rob Heckler new

Rob Heckler

Vice President, Information Technology Cyber Security

Learn more about Direct Biologics

We welcome your questions and inquiries – contact us today!